Hailie Smartinhaler
Commercial- Indications
- Asthma, COPD
Company intelligence / Profile preview
Adherium develops and commercializes connected respiratory medical devices—primarily smart inhalers—and a digital health platform to improve medication adherence and enable remote patient monitoring. Their products are FDA-cleared for use in asthma and COPD management. The company’s technologies are used by patients, healthcare providers, and researchers to track medication usage patterns in real time. Clinical results have demonstrated improved adherence rates among users of their smart inhaler systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adherium.